Publicaciones en colaboración con investigadores/as de Karolinska Institute (174)

2024

  1. A novel abbreviated version of the Luria neuropsychological diagnosis battery: reliability and convergent validity in Spanish older adults

    Journal of Clinical and Experimental Neuropsychology, Vol. 46, Núm. 6, pp. 579-587

  2. Charting Alzheimer’s Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways

    Journal of Clinical Medicine, Vol. 13, Núm. 14

  3. Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries

    Arthritis Care and Research

  4. Corrigendum to “ESPEN practical guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease” [Clin Nutr 43 (2024) 2238–2254, (S0261561424002802), (10.1016/j.clnu.2024.08.002)]

    Clinical Nutrition

  5. ESPEN practical guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2238-2254

  6. Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

    RMD Open, Vol. 10, Núm. 3

  7. Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial

    Clinical and Translational Allergy, Vol. 14, Núm. 1

  8. Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

    Leukemia, Vol. 38, Núm. 9, pp. 1985-1991

  9. Limited predictive value of bioelectrical phase angle for the development of sarcopenia in older Europeans

    Journal of Nutrition, Health and Aging, Vol. 28, Núm. 12

  10. Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 65

  11. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics

    Travel Medicine and Infectious Disease, Vol. 57

  12. Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

    Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892

  13. Short physical performance battery is not associated with falls and injurious falls in older persons: longitudinal data of the SCOPE project

    European Geriatric Medicine, Vol. 15, Núm. 3, pp. 831-842